Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction

Aarno Hautanen, Petri Toivanen, M. Mänttäri, Leena Tenkanen, Markku Kupari, V. Manninen, Kathleen M. Kayes, Scott Rosenfeld, Perrin C. White

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background - The -344C allele of a 2-allele (C or T) polymorphism in the promoter of the gene encoding aldosterone synthase (CYP1 IB2) is associated with increased left ventricular size and mass and with decreased baroreflex sensitivity, known risk factors for morbidity and mortality associated with myocardial infarction (MI). We hypothesized that this polymorphism was a risk factor for MI. Methods and Results - We used a nested case-control design to investigate the relationships between this polymorphism and the risk of nonfatal MI in 141 cases and 270 matched controls from the Helsinki Heart Study, a coronary primary prevention trial in dyslipidemic, middle-aged men. There was a nonsignificant trend of increasing risk of MI with number of copies of the -344C allele. However, this allele was associated in a gene dosage-dependent manner with markedly increased MI risk conferred by classic risk factors. Whereas smoking conferred a relative risk of MI of 2.50 (P=0.0001) compared with nonsmokers in the entire study population, the relative risk increased to 4.67 in - 344CC homozygous smokers (relative to nonsmokers with the same genotype, P=0.003) and decreased to 1.09 in -344TT homozygotes relative to nonsmokers with this genotype. Similar joint effects were noted with genotype and decreased HDL cholesterol level as combined risk factors. Conclusions - Smoking and dyslipidemia are more potent risk factors for nonfatal MI in males who have the -344C allele of CYP1 IB2.

Original languageEnglish (US)
Pages (from-to)2213-2218
Number of pages6
JournalCirculation
Volume100
Issue number22
StatePublished - Nov 30 1999

Fingerprint

Cytochrome P-450 CYP11B2
Myocardial Infarction
Alleles
Genes
Genotype
Smoking
Gene Dosage
Baroreflex
Homozygote
Primary Prevention
Dyslipidemias
HDL Cholesterol
Morbidity
Mortality

Keywords

  • Aldosterone
  • Genes
  • Genetics
  • Myocardial infarction
  • Risk factors

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Hautanen, A., Toivanen, P., Mänttäri, M., Tenkanen, L., Kupari, M., Manninen, V., ... White, P. C. (1999). Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation, 100(22), 2213-2218.

Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. / Hautanen, Aarno; Toivanen, Petri; Mänttäri, M.; Tenkanen, Leena; Kupari, Markku; Manninen, V.; Kayes, Kathleen M.; Rosenfeld, Scott; White, Perrin C.

In: Circulation, Vol. 100, No. 22, 30.11.1999, p. 2213-2218.

Research output: Contribution to journalArticle

Hautanen, A, Toivanen, P, Mänttäri, M, Tenkanen, L, Kupari, M, Manninen, V, Kayes, KM, Rosenfeld, S & White, PC 1999, 'Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction', Circulation, vol. 100, no. 22, pp. 2213-2218.
Hautanen A, Toivanen P, Mänttäri M, Tenkanen L, Kupari M, Manninen V et al. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation. 1999 Nov 30;100(22):2213-2218.
Hautanen, Aarno ; Toivanen, Petri ; Mänttäri, M. ; Tenkanen, Leena ; Kupari, Markku ; Manninen, V. ; Kayes, Kathleen M. ; Rosenfeld, Scott ; White, Perrin C. / Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. In: Circulation. 1999 ; Vol. 100, No. 22. pp. 2213-2218.
@article{067d9019530d408a84edf263ca5eaea1,
title = "Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction",
abstract = "Background - The -344C allele of a 2-allele (C or T) polymorphism in the promoter of the gene encoding aldosterone synthase (CYP1 IB2) is associated with increased left ventricular size and mass and with decreased baroreflex sensitivity, known risk factors for morbidity and mortality associated with myocardial infarction (MI). We hypothesized that this polymorphism was a risk factor for MI. Methods and Results - We used a nested case-control design to investigate the relationships between this polymorphism and the risk of nonfatal MI in 141 cases and 270 matched controls from the Helsinki Heart Study, a coronary primary prevention trial in dyslipidemic, middle-aged men. There was a nonsignificant trend of increasing risk of MI with number of copies of the -344C allele. However, this allele was associated in a gene dosage-dependent manner with markedly increased MI risk conferred by classic risk factors. Whereas smoking conferred a relative risk of MI of 2.50 (P=0.0001) compared with nonsmokers in the entire study population, the relative risk increased to 4.67 in - 344CC homozygous smokers (relative to nonsmokers with the same genotype, P=0.003) and decreased to 1.09 in -344TT homozygotes relative to nonsmokers with this genotype. Similar joint effects were noted with genotype and decreased HDL cholesterol level as combined risk factors. Conclusions - Smoking and dyslipidemia are more potent risk factors for nonfatal MI in males who have the -344C allele of CYP1 IB2.",
keywords = "Aldosterone, Genes, Genetics, Myocardial infarction, Risk factors",
author = "Aarno Hautanen and Petri Toivanen and M. M{\"a}ntt{\"a}ri and Leena Tenkanen and Markku Kupari and V. Manninen and Kayes, {Kathleen M.} and Scott Rosenfeld and White, {Perrin C.}",
year = "1999",
month = "11",
day = "30",
language = "English (US)",
volume = "100",
pages = "2213--2218",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "22",

}

TY - JOUR

T1 - Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction

AU - Hautanen, Aarno

AU - Toivanen, Petri

AU - Mänttäri, M.

AU - Tenkanen, Leena

AU - Kupari, Markku

AU - Manninen, V.

AU - Kayes, Kathleen M.

AU - Rosenfeld, Scott

AU - White, Perrin C.

PY - 1999/11/30

Y1 - 1999/11/30

N2 - Background - The -344C allele of a 2-allele (C or T) polymorphism in the promoter of the gene encoding aldosterone synthase (CYP1 IB2) is associated with increased left ventricular size and mass and with decreased baroreflex sensitivity, known risk factors for morbidity and mortality associated with myocardial infarction (MI). We hypothesized that this polymorphism was a risk factor for MI. Methods and Results - We used a nested case-control design to investigate the relationships between this polymorphism and the risk of nonfatal MI in 141 cases and 270 matched controls from the Helsinki Heart Study, a coronary primary prevention trial in dyslipidemic, middle-aged men. There was a nonsignificant trend of increasing risk of MI with number of copies of the -344C allele. However, this allele was associated in a gene dosage-dependent manner with markedly increased MI risk conferred by classic risk factors. Whereas smoking conferred a relative risk of MI of 2.50 (P=0.0001) compared with nonsmokers in the entire study population, the relative risk increased to 4.67 in - 344CC homozygous smokers (relative to nonsmokers with the same genotype, P=0.003) and decreased to 1.09 in -344TT homozygotes relative to nonsmokers with this genotype. Similar joint effects were noted with genotype and decreased HDL cholesterol level as combined risk factors. Conclusions - Smoking and dyslipidemia are more potent risk factors for nonfatal MI in males who have the -344C allele of CYP1 IB2.

AB - Background - The -344C allele of a 2-allele (C or T) polymorphism in the promoter of the gene encoding aldosterone synthase (CYP1 IB2) is associated with increased left ventricular size and mass and with decreased baroreflex sensitivity, known risk factors for morbidity and mortality associated with myocardial infarction (MI). We hypothesized that this polymorphism was a risk factor for MI. Methods and Results - We used a nested case-control design to investigate the relationships between this polymorphism and the risk of nonfatal MI in 141 cases and 270 matched controls from the Helsinki Heart Study, a coronary primary prevention trial in dyslipidemic, middle-aged men. There was a nonsignificant trend of increasing risk of MI with number of copies of the -344C allele. However, this allele was associated in a gene dosage-dependent manner with markedly increased MI risk conferred by classic risk factors. Whereas smoking conferred a relative risk of MI of 2.50 (P=0.0001) compared with nonsmokers in the entire study population, the relative risk increased to 4.67 in - 344CC homozygous smokers (relative to nonsmokers with the same genotype, P=0.003) and decreased to 1.09 in -344TT homozygotes relative to nonsmokers with this genotype. Similar joint effects were noted with genotype and decreased HDL cholesterol level as combined risk factors. Conclusions - Smoking and dyslipidemia are more potent risk factors for nonfatal MI in males who have the -344C allele of CYP1 IB2.

KW - Aldosterone

KW - Genes

KW - Genetics

KW - Myocardial infarction

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=0032729714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032729714&partnerID=8YFLogxK

M3 - Article

C2 - 10577993

AN - SCOPUS:0032729714

VL - 100

SP - 2213

EP - 2218

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 22

ER -